Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Although the Food and Drug Administration recently approved a class of drugs that slows the progression of Alzheimers, these drugs remain costly
But these studies were tiny and had no placebo group
DECLARATIONS Authors contributions Made substantial contributions to the conception and design of the study and performed data analysis and interpretation: Pirola CJ, Sookoian S Availability of data and materials Not applicable
The change was computed using a two-sided t-test at a significance level of 5%
US$ 20.19
US$ 24.62
US$ 20.36
US$ 20.41
US$ 29.81
